Who owns the DURECT trademark?

The DURECT trademark is owned by MEDICIS PHARMACEUTICAL CORPORATION.

What class is the DURECT trademark registered in?

The DURECT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DURECT?

The USPTO serial number for DURECT is 97401062.

What is the registration number for DURECT?

DURECT is registered under USPTO registration number 7402808.

Sealvo

Home Search: DURECTDURECT #97401062

Back

Updated Oct 27, 2026·12 searches this week

View on USPTO TSDR Find similar marks

DUR

USPTO Trademark Record

REGISTERED

DURECT

SN 97401062·Reg 7402808·Filed May 09, 2022

Owner MEDICIS PHARMACEUTICAL CORPORATION

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DURECT (Serial No. 97401062), Registration No. 7402808, is a registered US trademark filed on May 09, 2022 by MEDICIS PHARMACEUTICAL CORPORATION. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 28, 2030

Mark Intelligence

DURECT (Reg. #7402808) is a registered US trademark that has been protecting its owner, MEDICIS PHARMACEUTICAL CORPORATION, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 09, 2022

SERIAL

97401062

REG#

7402808

REGISTERED

May 28, 2024

Filing Information

StatusREGISTERED

Filing DateMay 09, 2022

Serial Number97401062

Registration No.7402808

Registration DateMay 28, 2024

Status DateMay 28, 2024

Published for OppositionMay 23, 2023

Filing Basis & Declarations

Use Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Dec 07, 2023

First use in commerce: Dec 07, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

38 events

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Apr 22, 2026

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Sep 23, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Sep 23, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 23, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 23, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 23, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

DIVISIONAL REQUEST RECEIVED

Jun 17, 2024

DIVISIONAL REQUEST RECEIVED

DIVISIONAL PROCESSING COMPLETE

Jun 17, 2024

DIVISIONAL PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 11, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

REGISTERED-PRINCIPAL REGISTER

May 28, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 28, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 23, 2024

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 23, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

Apr 23, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 22, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS REQUEST TO DIVIDE RECEIVED

Apr 03, 2024

TEAS REQUEST TO DIVIDE RECEIVED

TEAS STATEMENT OF USE RECEIVED

Apr 03, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Apr 03, 2024

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 19, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Jan 17, 2024

SOU EXTENSION 1 GRANTED

SOU EXTENSION 1 FILED

Jan 17, 2024

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Jan 17, 2024

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 18, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 23, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 23, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 03, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 18, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 18, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 18, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 18, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 18, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Mar 02, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 02, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 02, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 27, 2023

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 14, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 13, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 12, 2022

NEW APPLICATION ENTERED

Other Marks by MEDICIS PHARMACEUTICAL CORPORATION

Additional USPTO filings from the same owner.

LUZ

LUZU

85777408

Medicis Pharmaceutical Corporation

REGISTERED

DUR

DURECT

97401100

MEDICIS PHARMACEUTICAL CORPORATION

REGISTERED

DUR

DURECT

76137001

MEDICIS PHARMACEUTICAL CORPORATION

REGISTERED

DUR

DURECT

76975854

MEDICIS PHARMACEUTICAL CORPORATION

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

DUR

DURECT

97401100

MEDICIS PHARMACEUTICAL CORPORATION

REGISTERED

DUR

DURECT

75625710

Durect Corporation

ABANDONED

Other Marks by Jeremy Blackowicz

Additional USPTO filings handled by the same attorney of record.

LOG

LogoMark

79438645

REGISTERED

ORA

ORATALKS

99412491

REGISTERED

ARA

ARAZLO

88086551

REGISTERED

ORA

ORAPHARMA

75878686

REGISTERED

DURECT

Run a conflict check

Other Marks by MEDICIS PHARMACEUTICAL CORPORATION

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Jeremy Blackowicz

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company